Literature DB >> 22124706

Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma.

Damiana Pieragostino1, Sonia Bucci, Luca Agnifili, Vincenzo Fasanella, Simona D'Aguanno, Alessandra Mastropasqua, Marco Ciancaglini, Leonardo Mastropasqua, Carmine Di Ilio, Paolo Sacchetta, Andrea Urbani, Piero Del Boccio.   

Abstract

Primary open angle (POAG) and pseudoexfoliative glaucoma (PXG) are the most common primary and secondary forms of glaucoma, respectively. Even though the patho-physiology, aqueous humor composition, risk factors, clinical features, therapy and drug induced ocular surface changes in POAG and PXG have been widely studied, to date information concerning tear protein characterization is lacking. Tears are a source of nourishment for ocular surface tissues and a vehicle to remove local waste products, metabolized drugs and inflammatory mediators produced in several ophthalmic diseases. In glaucoma, the proteomic definition of tears may provide insights concerning patho-physiology of the disease and ocular surface modifications induced by topical therapy. Our study aimed at characterizing protein patterns in tears of patients with medically controlled POAG and PXG. A comparative tears proteomic analysis by label-free LC-MS(E) highlighted differences in the expression of several proteins in the two glaucoma sub-types and control subjects, highlighting inflammation pathways expressed in both diseases. Results were independently reconfirmed by SDS-PAGE and linear MALDI-TOF MS, validating altered levels of Lysozyme C, Lipocalin-1, Protein S100, Immunoglobulins and Prolactin Inducible Protein. Moreover, we found a differential pattern of phosphorylated Cystatin-S that distinguishes the two pathologies. The most relevant results suggest that in both pathologies there may be active inflammation pathways related to the disease and/or induced by therapy. We show, for the first time, tear protein patterns expressed under controlled intraocular pressure conditions in POAG and PXG subjects. These findings could help in the understanding of molecular machinery underlying these ophthalmologic diseases, resulting in early diagnosis and more specific therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124706     DOI: 10.1039/c1mb05357d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  24 in total

Review 1.  A decade of proteomics studies of glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Proteomics Clin Appl       Date:  2014-02-16       Impact factor: 3.494

Review 2.  Major review: Molecular genetics of primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2017-05-10       Impact factor: 3.467

Review 3.  The Human Eye Proteome Project: perspectives on an emerging proteome.

Authors:  Richard D Semba; Jan J Enghild; Vidya Venkatraman; Thomas F Dyrlund; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-08       Impact factor: 3.984

4.  Integrated proteome and HPLC analysis revealed quercetin-mediated inhibition of aflatoxin B1 biosynthesis in Aspergillus flavus.

Authors:  Shraddha Tiwari; Jata Shankar
Journal:  3 Biotech       Date:  2018-01-03       Impact factor: 2.406

Review 5.  The Human Eye Proteome Project: Updates on an Emerging Proteome.

Authors:  Meleha T Ahmad; Pingbo Zhang; Craig Dufresne; Luigi Ferrucci; Richard D Semba
Journal:  Proteomics       Date:  2018-03       Impact factor: 3.984

6.  Molecular Biomarkers for Glaucoma.

Authors:  Gala Beykin; Jeffrey L Goldberg
Journal:  Curr Ophthalmol Rep       Date:  2019-07-23

Review 7.  Multiplex protein analysis for the study of glaucoma.

Authors:  Gülgün Tezel
Journal:  Expert Rev Proteomics       Date:  2021-10-29       Impact factor: 3.940

Review 8.  A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2013-02-05       Impact factor: 21.198

9.  Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study.

Authors:  Wenqing Zhu; Xiangmei Kong; Jianjiang Xu; Xinghuai Sun
Journal:  J Ophthalmol       Date:  2015-06-15       Impact factor: 1.909

Review 10.  Discovery and clinical translation of novel glaucoma biomarkers.

Authors:  Gala Beykin; Anthony M Norcia; Vivek J Srinivasan; Alfredo Dubra; Jeffrey L Goldberg
Journal:  Prog Retin Eye Res       Date:  2020-07-10       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.